Factors to Consider in the Treatment of Early Relapsed/Refractory Multiple Myeloma
 | Factors to Consider in the Treatment of Early Relapsed/Refractory Multiple Myeloma CME, CPE Sikander Ailawadhi, MD | |
| Release Date: February 07, 2020 Expiration Date: February 07, 2021 | ||
Managing a newly diagnosed patient with multiple myeloma can present challenges. In this activity, Dr. Ailawadhi covers the key aspects of treatment for patients living with relapsed or refractory multiple myeloma. Provided by MediCom Worldwide, Inc.This activity is supported by an educational grant from Celgene Corporation. | ||
| Begin, Earn CreditView Only, No Credit | ||